In a report released yesterday, Courtney Breen from Bernstein maintained a Buy rating on Gilead Sciences (GILD – Research Report), with a price target of $105.00. Discover top-rated stocks from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback